Abstract:Target-based drug discovery technology based on cell membrane targets has gained significant traction and has been steadily advancing. However, current methods still face certain limitations that need to be addressed. One of the challenges is the laborious preparation process of screening materials, which can be time-consuming and resource-intensive. Additionally, there is a potential issue of non-specific adsorption caused by carrier materials, which can result in false-positive results and compromise the accuracy of the screening process. To address these challenges, this paper proposes a target-based cell membrane affinity ultrafiltration technology for active ingredient discovery in natural products. In this technique, the cell membranes of human lung adenocarcinoma epithelial cells (A549) with a high expression of epidermal growth factor receptor (EGFR) were incubated with candidate drugs and then transferred to an ultrafiltration tube. Through centrifugation, components that interacted with EGFR were retained in the ultrafiltration tube as "EGFR-ligand" complex, while the components that did not interact with EGFR were separated. After thorough washing and eluting, the components interacting with EGFR were dissociated and further identified using LC–MS, enabling the discovery of bioactive compounds. Moreover, the target-based cell membrane affinity ultrafiltration technology exhibited commendable binding capacity and selectivity. Ultimately, this technology successfully screened and identified two major components from the Curcumae Rhizoma-Sparganii Rhizoma (CS) herb pair extracts, which were further validated for their potential anti-tumor activity through pharmacological experiments. By eliminating the need for laborious preparation of screening materials and the potential non-specific adsorption caused by carriers, the development of target-based cell membrane affinity ultrafiltration technology provides a simplified approach and method for bioactive compounds discovery in natural sources.

Recent advances in cell membrane-coated technology for drug discovery from natural products

Coating nanoparticles with cell membranes for targeted drug delivery

Polymer membrane and cell models for drug discovery.

Advances in cell membrane-based biomimetic nanodelivery systems for natural products

Cell Membrane Coating Technology: A Promising Strategy for Biomedical Applications

A Machine-Learning-Based Bibliometric Analysis of Cell Membrane-Coated Nanoparticles in Biomedical Applications over the Past Eleven Years

Cell-membrane engineering strategies for clinic-guided design of nanomedicine

Biomedical Applications of Cell Membrane‐Based Biomimetic Nano‐Delivery System

Recent advances in screening active components from natural products based on bioaffinity techniques

Development of target-based cell membrane affinity ultrafiltration technology for a simplified approach to discovering potential bioactive compounds in natural products

Genetically Engineered Cell Membrane-Coated Nanoparticles with High-Density Customized Membrane Receptor for High-Performance Drug Lead Discovery

Membrane engineering of cell membrane biomimetic nanoparticles for nanoscale therapeutics

Engineered Cell Membrane-Camouflaged Nanomaterials for Biomedical Applications

Drugging Membrane Protein Interactions

Recent advances in mesenchymal stem cell membrane-coated nanoparticles for enhanced drug delivery

Recent Advances of Cell Membrane‐Coated Nanomaterials for Biomedical Applications

Recent advances in cell membrane camouflage-based biosensing application

Cell membrane-coated nanoparticles: a novel multifunctional biomimetic drug delivery system

Biomembrane-based nanostructures for cancer targeting and therapy: From synthetic liposomes to natural biomembranes and membrane-vesicles

Virtual Screening on Natural Products for Discovering Active Compounds and Target Information

Cell Membrane as A Promising Therapeutic Target: From Materials Design to Biomedical Applications